Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Allergy and immunotoxicology in preventive and clinical medicine from theory to practice: Environmental factors in Bronchial Asthma].
Hisada T, Nishimura Y, Dobashi K, Yoshida T, Itoh T, Morimoto Y, Suganuma N, Li Q, Wada H, Ueda A, Kayama F, Satoh K, Satoh M, Shibata E, Takeshita T, Yanagisawa H, Tsunoda M. Hisada T, et al. Sangyo Eiseigaku Zasshi. 2024 Nov 12. doi: 10.1539/sangyoeisei.2024-009-A. Online ahead of print. Sangyo Eiseigaku Zasshi. 2024. PMID: 39537181 Free article. Japanese.
Japanese clinical practice guide 2022 for hypersensitivity pneumonitis.
Tomioka H, Miyazaki Y, Inoue Y, Egashira R, Kawamura T, Sano H, Johkoh T, Takemura T, Hisada T, Fukuoka J; committee of Japanese Respiratory Society for Japanese clinical practice guide 2022 for hypersensitivity pneumonitis. Tomioka H, et al. Among authors: hisada t. Respir Investig. 2024 Jan;62(1):16-43. doi: 10.1016/j.resinv.2023.07.007. Epub 2023 Nov 4. Respir Investig. 2024. PMID: 37931427 Review.
A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy.
Kobayashi N, Sunaga N, Yatomi M, Wakamatsu I, Muto S, Ikota H, Yamaguchi R, Ohtaki Y, Nagashima T, Kubo N, Masuda T, Miura Y, Tsurumaki H, Sakurai R, Koga Y, Hisada T, Maeno T. Kobayashi N, et al. Among authors: hisada t. Thorac Cancer. 2024 Dec 27. doi: 10.1111/1759-7714.15512. Online ahead of print. Thorac Cancer. 2024. PMID: 39731296 Free article.
Evaluation of the Efficacy and Accuracy of Super-Flexible Three-Dimensional Heart Models of Congenital Heart Disease Made via Stereolithography Printing and Vacuum Casting: A Multicenter Clinical Trial.
Shiraishi I, Yamagishi M, Hoashi T, Kato Y, Iwai S, Ichikawa H, Nishii T, Yamagishi H, Yasukochi S, Kawada M, Suzuki T, Shinkawa T, Yoshimura N, Inuzuka R, Hirata Y, Hirose K, Ikai A, Sakamoto K, Kotani Y, Kasahara S, Hisada T, Kurosaki K. Shiraishi I, et al. Among authors: hisada t. J Cardiovasc Dev Dis. 2024 Dec 3;11(12):387. doi: 10.3390/jcdd11120387. J Cardiovasc Dev Dis. 2024. PMID: 39728278 Free PMC article.
Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy.
Miyamoto A, Michimae H, Nakahara Y, Akagawa S, Nakagawa K, Minegishi Y, Ogura T, Hontsu S, Date H, Takahashi K, Homma S, Kishi K; Investigators Group for Lung Cancer and IIP. Miyamoto A, et al. Sci Rep. 2024 May 3;14(1):10162. doi: 10.1038/s41598-024-60833-w. Sci Rep. 2024. PMID: 38702426 Free PMC article.
A case of autoimmune pulmonary alveolar proteinosis during the course of treatment of rapidly progressive interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositis.
Yatomi M, Akasaka K, Sato S, Chida M, Kanbe M, Sawada H, Yokota I, Wakamatsu I, Muto S, Sato M, Yamaguchi K, Miura Y, Tsurumaki H, Sakurai R, Hara K, Koga Y, Sunaga N, Yamakawa H, Matsushima H, Yamazaki S, Endo Y, Motegi SI, Hisada T, Maeno T. Yatomi M, et al. Among authors: hisada t. BMC Pulm Med. 2024 Apr 8;24(1):170. doi: 10.1186/s12890-024-02989-9. BMC Pulm Med. 2024. PMID: 38589870 Free PMC article.
Glasgow prognostic score and body mass index predict short-term discontinuation of the antifibrotic agents pirfenidone and nintedanib.
Takehara K, Koga Y, Hachisu Y, Utsugi M, Sawada Y, Saito Y, Yoshimi S, Yatomi M, Tsurumaki H, Shin Y, Wakamatsu I, Kasahara N, Yamaguchi K, Umetsu K, Kouno S, Nakagawa J, Sunaga N, Maeno T, Hisada T. Takehara K, et al. Among authors: hisada t. Respir Investig. 2024 May;62(3):388-394. doi: 10.1016/j.resinv.2024.02.012. Epub 2024 Mar 8. Respir Investig. 2024. PMID: 38460356
396 results